An in vitro diagnostic test kit for the detection of cancer antigen 15-3 (CA15-3), a tumor marker. The product is CE certified and complies with European in vitro diagnostic product directive 98/79/EC. It is manufactured by ISO13485 certified facilities in Gothenburg, Sweden and Malvern, Pennsylvani...
Manufactured by
China
CanAg Diagnostics (Fujirebio) is a global leader in in-vitro diagnostics and the world's largest manufacturer of tumor marker gold standards. The company provides detection products for most common solid tumors including gastrointestinal, squamous cell, liver, pancreatic, prostate, ovarian, skin, and lung cancers. All products are manufactured in ISO13485-certified facilities in Sweden and USA, supplying tumor marker antigens and antibodies to major international diagnostic manufacturers.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
K.Bio Sciences Co., Ltd.
Thailand · 1 relevant product
VEDALAB SAS
France · 9 relevant products
Medix Biochemica Oy AB
Finland · 2 relevant products
MedLevensohn
Brazil · 2 relevant products
Boditech Med Inc.
South Korea · 2 relevant products
Fujirebio Europe
Belgium · 1 relevant product
HeavyBio, Inc
China · 4 relevant products
STRATEC/Diatron
Germany · 1 relevant product
Nanjing Poclight Biotechnology Co.,Ltd.
China · 3 relevant products
J. Mitra & Co. Pvt. Ltd.
India · 1 relevant product
49 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 93 closest product alternatives
K.Bio Sciences Co., Ltd. · Thailand
Enzyme immunoassay test kits developed for clinical diagnostic applications. These assays provide reliable immunological detection across various medical testing scenarios.
VEDALAB SAS · France
Immunochromatographic rapid test for the quantitative determination of Cancer Antigen 15-3 (CA 15-3) in whole blood, serum or plasma. Measuring range: 5-200 IU/mL. Reading time: 10 minutes.
VEDALAB SAS · France
Immunochromatographic rapid test for the quantitative determination of Cancer Antigen 15-3 (CA 15-3) in whole blood, serum or plasma. Measuring range: 5–200 IU/mL. Reading time: 10 minutes.
Medix Biochemica Oy AB · Finland
A diagnostic test for measuring Cancer Antigen 15-3 (CA15-3) levels in blood samples. This test is used in clinical laboratories for assessment and monitoring of breast cancer.
MedLevensohn · Brazil
A rapid diagnostic test for detecting CA15-3 antigen, a tumor marker commonly used in breast cancer monitoring and diagnosis.
Boditech Med Inc. · South Korea
A cancer biomarker reagent useful in the management and monitoring of breast cancer.
Fujirebio Europe · Belgium
Manual or semi-automated immunoassay kit for cancer antigen detection. Used for oncology diagnostics and tumor marker measurement.
HeavyBio, Inc · China
Mouse antibody (similar to MA552) for CA15-3 detection in CLIA applications. Used for monitoring breast cancer recurrence, metastasis detection, and early diagnosis when combined with other tumor markers.
HeavyBio, Inc · China
Humanized antibody (similar to DF3) for CA15-3 capture and detection in FIA/CLIA applications. Used to observe breast cancer recurrence after treatment, monitor metastasis, and improve early diagnosis sensitivity when combined with other markers.
STRATEC/Diatron · Germany
In-vitro diagnostic test for detecting tumor markers and cancer-related antigens in blood and other biological samples. The test aids in cancer screening, diagnosis, and treatment monitoring.
HeavyBio, Inc · China
Mouse antibody (similar to MA695) for CA15-3 capture in CLIA applications. Recognizes MUC-1 glycoprotein for breast cancer monitoring and detection of malignant tumors.
MedLevensohn · Brazil
A rapid diagnostic test for detecting carcinoembryonic antigen (CEA), a tumor marker used in cancer screening and monitoring.
81 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products